Efalizumab Biosimilar, Human CD11a mAb
Item Information
Catalog #
Size
Price
Description
Efalizumab is a humanized IgG1 monoclonal antibody specific for human CD11a used to treat moderate to severe plaque psoriasis. This Efalizumab biosimilar has the same amino acid sequence as Efalizumab.
Product Overview
Isotype
IgG1 kappa
Source
Produced in the CHO stable cell line with gentamycin.
Formulation
0.2-uM filtered solution, pH 6.0, no stabilizers or preservatives
Purity
>95% by SDS-PAGE under reducing conditions and HPLC
Endotoxin
<1 EU/mg (LAL method)
Specificity/Sensitivity
Binds to human CD11a.
Storage
4°C if used within 1 month, -20°C otherwise
Shipping Information
Shipped with an ice pack.
Application
ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and assays for studying the biological pathways affected by Efalizumab.
For Research Use Only. Not for use in diagnostic procedures.